Related Experiment Video
Updated: Jun 2, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
Tereza Lopotová1, Markéta Záčková, Hana Klamová
1Department of Molecular Genetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic. tereza.lopotova@uhkt.cz
Abstract:
Chronic myeloid leukemia (CML) is caused by constituve activity of BCR-ABL tyrosine kinase. Despite of high efficiency of imatinib, selective BCR-ABL inhibitor, about 30% of patients develop resistance. Novel markers and targets for therapy are thus necessary. MicroRNAs are small intereference RNAs whose role in physiological and malignant hematopoiesis has been shown. This study is focused on miR-451 in CML. Following our observation of miR-451 downregulation in CML, we further show its relation to BCR-ABL activity. Our data together with current literature indicate a more complex relationship of miR-451 and BCR-ABL in CML.
Insights
This study investigates microRNA-451 (miR-451) in chronic myeloid leukemia (CML). We found miR-451 is downregulated in CML and linked to BCR-ABL activity, suggesting a complex role in the disease.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Chronic myeloid leukemia (CML) is driven by BCR-ABL tyrosine kinase activity.
- Imatinib resistance affects approximately 30% of CML patients, necessitating new therapeutic targets.
- MicroRNAs, including miR-451, play roles in hematopoiesis and cancer.
Purpose of the Study:
- To investigate the role of miR-451 in chronic myeloid leukemia.
- To explore the relationship between miR-451 expression and BCR-ABL activity in CML.
Main Methods:
- Analysis of miR-451 expression levels in CML samples.
- Correlation studies between miR-451 and BCR-ABL activity.
Main Results:
- miR-451 was observed to be downregulated in CML.
- A relationship between miR-451 downregulation and BCR-ABL activity was identified.
Conclusions:
- miR-451 represents a potential novel marker or therapeutic target in CML.
- The interplay between miR-451 and BCR-ABL in CML is complex and warrants further investigation.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic cells are...

